Peak6 Investments LLC Cytokinetics Inc Call Options Transaction History

Peak6 Investments LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$47.86 - $75.05 $904,554 - $1.42 Million	-18,900 Reduced 33.1%	38,200 $2.07 Million
Q1 2024 May 14, 2024	BUY	$63.75 - $108.06 $784,125 - $1.33 Million	12,300 Added 27.46%	57,100 $4 Million
Q4 2023 Feb 13, 2024	BUY	$26.88 - $83.49 $792,960 - $2.46 Million	29,500 Added 192.81%	44,800 $3.74 Million
Q3 2023 Nov 13, 2023	SELL	$29.46 - $36.61 $11,784 - $14,644	-400 Reduced 2.55%	15,300 $450,000
Q2 2023 Aug 11, 2023	BUY	$32.62 - $40.75 $512,133 - $639,775	15,700 New	15,700 $512,000
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $192,700 - $272,600	5,000 New	5,000 $242,000
Q2 2022 Aug 12, 2022	SELL	$33.93 - $48.92 $2.44 Million - $3.51 Million	-71,800 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$29.74 - $46.0 $2.14 Million - $3.3 Million	71,800 New	71,800 $2.64 Million

406

126M

3.29M

2.01M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.93B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.